{"title":"沙利度胺胚胎病:一个长期被遗忘但重要的是要记住的综合征","authors":"F. Hinoshita","doi":"10.23880/MJCCS-16000217","DOIUrl":null,"url":null,"abstract":"I have been heading up the official group to support and examine thalidomide victims funded by Ministry of Health, Labour and Welfare in Japan for several years. Today it is well known that thalidomide and its derivatives came into the spotlight because they were well recognized to have favorable effects for leprosy, multiple myeloma (MM) and a few other diseases [1]. Consequently, thalidomide was approved and licensed around the world, and it is currently used in many countries.","PeriodicalId":375015,"journal":{"name":"Medical Journal of Clinical Trials & Case Studies","volume":"92 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Thalidomide Embryopathy: A Syndrome Long Forgotten but Important to be remembered\",\"authors\":\"F. Hinoshita\",\"doi\":\"10.23880/MJCCS-16000217\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"I have been heading up the official group to support and examine thalidomide victims funded by Ministry of Health, Labour and Welfare in Japan for several years. Today it is well known that thalidomide and its derivatives came into the spotlight because they were well recognized to have favorable effects for leprosy, multiple myeloma (MM) and a few other diseases [1]. Consequently, thalidomide was approved and licensed around the world, and it is currently used in many countries.\",\"PeriodicalId\":375015,\"journal\":{\"name\":\"Medical Journal of Clinical Trials & Case Studies\",\"volume\":\"92 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medical Journal of Clinical Trials & Case Studies\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.23880/MJCCS-16000217\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Journal of Clinical Trials & Case Studies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23880/MJCCS-16000217","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Thalidomide Embryopathy: A Syndrome Long Forgotten but Important to be remembered
I have been heading up the official group to support and examine thalidomide victims funded by Ministry of Health, Labour and Welfare in Japan for several years. Today it is well known that thalidomide and its derivatives came into the spotlight because they were well recognized to have favorable effects for leprosy, multiple myeloma (MM) and a few other diseases [1]. Consequently, thalidomide was approved and licensed around the world, and it is currently used in many countries.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
